REG vs ROIV · P/E 34, rev $1.55B vs rev $8.3M
Regency Centers Corporation (REG) versus Roivant Sciences Ltd (ROIV) — a side-by-side from cached financials, not a winner call.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Roivant Sciences Ltd (ROIV) is a biotechnology company listed on US.
Latest reported REG revenue for 2025-12-31 was $1.55B. Net income was $527.5M. Revenue was up 6.9% from 2024-12-31 to 2025-12-31. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Latest reported ROIV revenue for 2026-03-31 was $8.3M. Net income was -$299.8M. Revenue was down 71.6% from 2025-03-31 to 2026-03-31. ROIV currently screens at market cap $7.47B.
REG currently screens at market cap $12.93B and trailing P/E 33.5. ROIV currently screens at market cap $7.47B.
Not investment advice. Open the REG and ROIV stock pages for the full models.
Not investment advice.